We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Futura Medical Plc | LSE:FUM | London | Ordinary Share | GB0033278473 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.05 | -3.01% | 33.80 | 33.85 | 34.65 | 34.75 | 33.80 | 34.25 | 199,046 | 14:00:58 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -5.85M | -0.0194 | -17.42 | 101.64M |
Date | Subject | Author | Discuss |
---|---|---|---|
16/8/2022 12:01 | All Futura have done is also allow Reckitt to sell lubricants/arousal gels as medical device placebo treatments for ED. And report Med3000 to the ASA, FTC etc for being misleading if it doesn't inform consumers that Med3000 itself has no proven effect in ED beyond a placebo. As it has not proven efficacy in a placebo controlled study or even against any standard cooling lubricant/arousal gels.https://neo.lif | lbo | |
16/8/2022 11:58 | 325 million men the lbo says do no exist ROFLMAO | j777j | |
16/8/2022 11:53 | Lbo's anal prolapse is on the floor he is on so much overtime | j777j | |
16/8/2022 11:53 | I wonder how big a lie the ASA, EU courts and FTC will say this is? One thing is for sure. Companies need a lot of cash to market a placebo and fight the lawsuits and paying the fines like the FTC judgements Placebo-nomics: how bad was what Nurofen did? Australian courts have ordered the makers of the brand to stop repackaging identical painkillers for different pains where does marketing end and deception begin? Lies come in a wide range of ethical shapes and sizes. There are white ones, diplomatic ones, and there are mean, self-serving ones. Apparently there are even nice, Christmassy ones. The Australian federal court yesterday ordered the drug giant Reckitt Benckiser to stop selling identical products marketed as specific Nurofen varieties for back pain, period pain, migraine pain and tension headaches. The company admitted the drugs sold in different coloured packets all contained the same active ingredient: 342mg of ibuprofen lysine. It also sold them at almost twice the price of Nurofens standard ibuprofen products. Whether this constitutes deception or just marketing is probably one for the lawyers to argue over | lbo | |
16/8/2022 11:51 | Its all a 'swindle' by the rampers!https://pubm | lbo | |
16/8/2022 11:49 | £65 million a week to futura turns it into the billionaires club of market cap | j777j | |
16/8/2022 11:48 | Tried ,tested and about to become the fastest ever selling OTC topical product for ED Fasten seatbelts | j777j | |
16/8/2022 11:27 | You were posting similar ramps before the Phase 3 failure in 2019 and then share price collapsed below 10p LOL J777J - 28 Nov 2019 - 07:35:10 - 6443 of 11639 New 15 page buy note out today from Liberum. A strong positive outcome would imply 149p share | lbo | |
16/8/2022 11:21 | The numbers are staggering. | j777j | |
16/8/2022 11:21 | Bear in mind 10% of the 300 million men are contra indicated to the current prescription medications. So that is 30 million men right there. At 217p wholesale and using just once a week that is over £65 million A WEEK to Futura | j777j | |
16/8/2022 11:17 | Our research indicates this could be worth north of 400p a share. Based on just a 10% market share. | j777j | |
16/8/2022 11:13 | Here is another company who made false claims about its medical device being clinically proven and that the FDA had reviewed and approved the device for its advertised pain relief and other health benefits. The FTC challenged all those claims as false and hit them with a judgement for $22 million. The FDA does not approve class 1 or 2 devices like Willow Curve and Med3000!https://www. | lbo | |
16/8/2022 10:53 | Trinity Research even admit the hypothesised effects 'believed' to be happening by Futura are 'disputed' and they admitted no mechanism of action has to be even shown to get a medical device approved. But unfortunately it does to need be proven to substantiate its marketing claims or fall foul of the FTC, ASA etchttps://www.ftc.g | lbo | |
16/8/2022 10:29 | ROFLMAO A supposed multibillion dollar golden goose with no patent protection! If the ‘magic’ does work and is not just a placebo then anyone can make a similar alcohol and water cooling gel themselves. What a pump and soon to be dumped ‘swindle&rsquo The composition of the invention contained: ethanol: 33%; water: 35%; glycerol: 24%; propylene glycol: 6%; Carbopol® Ultrez 10: 1%. pH was adjusted to 5.25 with potassium hydroxide solution. The ethanol used in the manufacture of the composition was absolute ethanol (i.e. 100% ethanol free from water) such that the final composition contained 33% of pure ethanol. If a lower grade of ethanol was used which contained impurity amounts of water (e.g. 96% ethanol), then the amount used would have to be adjusted to ensure the final composition contained the correct amount of the components, i.e. 33% pure ethanol and 35% water. Kama Sutra Intensify Plus Female Arousal Gel Cooling 15 ml Ingredients: Water, Propylene Glycol, Denatured Alcohol Voltaren vehicle gel is the carrier substance of the topical Voltaren products. This vehicle gel is especially formulated to be easily applied on the skin, while providing some sensory benefits. The present study aims to substantiate the widely perceived hydrating and cooling effect of Voltaren vehicle | lbo | |
16/8/2022 09:08 | Pfizer et Al are terrified their multi billion dollar golden goose is a kit to be taken away by a tiny UK co. | j777j | |
16/8/2022 09:05 | The most significant breakthrough in the treatment of ED in Iver 20 years.No wonder lbo is being paid to try and deramp.This will go straight to OTC and will sell in the hundreds of millions of dollars much faster than any predictions.Worth ££££'s per share.Almost there folks just days away from release | j777j | |
15/8/2022 15:08 | Imagine anyone can make their own alcohol and water gel and supposedly all the mild to moderate ED in the world will be solved! No wonder Glaxo walked away for ‘normal commercial reasons! LOL GlaxoSmithKline unexpectedly handed back the development rights to Futuras erectile dysfunction gel. We are not going to progress on this particular compound for normal commercial reasons which we do not wish to go into, GSK said. The cooling effect of a topically applied product can be evaluated using a validated handheld thermal imaging system. When the gel matrix is destroyed after application to the skin, the bound water and alcohol evaporates and a measurable cooling-effect results. Even Dermasys on its own has no patent anymore. The Dermasys trademark predates by many years the umbrella patents covering MED2005 (Dermasys and GTN) and TPR100 (Dermasys and Diclofenac) which are all expiring soon also. from Trinity in a previous note regarding the MED2005 patent: the long development period resulted in a material erosion of the patent life, with the original formulation patent expected to expire in 2025 Dermasys is even older so is off patent 2002 plus 20 years = 2022 The DermaSys(R) technology was originally developed by Futura for use in the Company's topical treatment for erectile dysfunction, MED2002 Under the terms of the agreement, Thornton & Ross will conduct the manufacturing scale-up of TPR100 and hold rights to manufacture, market and distribute the product in the UK for the lifetime of the product's patents, which run to at least 2028 in the UK | lbo | |
15/8/2022 14:32 | Yep. You know when things are going well for FUM because LiarBO gets even more repetitive than usual, if such a thing is possible. | petroc |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions